Canada's leading OBGYNs to discuss Maternal Mortality, Abortion, Menopause and Ovarian Cancer at annual conference
OTTAWA, June 05, 2023 (GLOBE NEWSWIRE) -- The Society of Obstetricians and Gynaecologists of Canada (SOGC) will be holding its Annual Clinical and Scientific Conference this June 6-9 in Ottawa. This 4-day event will include discussion panels, workshops, and a multitude of plenary sessions on key issues for Women's Health.
"We believe this is a wonderful opportunity to showcase what the SOGC does to improve women's sexual and reproductive health. Many leading physicians will be presenting their findings on a variety of subjects, with valuable knowledge that will benefit us all, not just professional healthcare providers", said Dr. Diane Francoeur, CEO of the SOGC. "This is our signature continuing medical education forum and we are very proud of what we have to offer this year."
Topics covered:
FEATURED - Inaugural Summit on the Prevention of Maternal Mortality in Canada. Yes, there are still deaths occurring in Canada during delivery or after. Doctors will discuss prevention toolkits, trends in severe maternal morbidity, impact on mental health, what are UK and USA doing, etc. ? Tuesday, June 6th.
Medication abortion - as planned vs not as planned (with Dr. Bruce B. Allan, MD) ? Wednesday, June 7th.
Managing menopause in 2023 (with Dr. Michelle R. Jacobson, MD) - Wednesday June 7th.
Addressing inequities in reproductive health globally: Making the seemingly impossible possible (with Dr. Astrid Christoffersen-Deb, MD) ? Thursday, June 8th.
New development in management of endometrial and ovarian cancer (with Dr. Sarah Sinasac, MD, and Dr. Johanne Weberpals) ? Friday, June 9th
Over 400 obstetricians, gynaecologists and physicians will attend the biggest Ob/Gyn event in Canada.
A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovation & Technology (iHealthtech) has unveiled a novel approach to stimulate muscle, by way of using brief and mild pulsed electromagnetic...
PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, today announced the introduction of GlueSEEKERtm. The new phenotypic screening platform expands the Company's capabilities in this emerging...
The National Comprehensive Cancer Network® (NCCN®)?a global nonprofit responsible for leading cancer treatment guidelines?is taking part in two events in Warsaw focused on advancing...
The 10th European Stroke Organization Congress (ESOC), held in Basel, Switzerland from May 15 to 17, 2024, showcased six studies on Sanbexin® (Edaravone and Dexborneol Concentrated Solution for Injection) and a new dosage form of sublingual tablets...
GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo Syndrome Type A) treatment, GC1130A....
PathAI, a global leader in AI-powered pathology, today announced a new Early Access Program (EAP) to drive adoption of its AISightTM Image Management System (IMS) in Mainland Europe.1 Earlier in 2023, PathAI announced a similar program for...